Jacques Koolen

15.3k citations
149 papers · 10.4k · 7 hit papers · h-index 48

Impact in

  • Surgery top 0.05%
    • Coronary Interventions and Diagnostics
    • Acute Myocardial Infarction Research
    • Cardiac Valve Diseases and Treatments
    • Antiplatelet Therapy and Cardiovascular Diseases

Papers in

    • Coronary Interventions and Diagnostics 98
    • Hemodynamic Monitoring and Therapy 6
    • Peripheral Artery Disease Management 6
    • Cardiac Valve Diseases and Treatments 18
    • Cardiac, Anesthesia and Surgical Outcomes 13
    • Acute Myocardial Infarction Research 10
    • Antiplatelet Therapy and Cardiovascular Diseases 7

Jacques Koolen

147 papers receiving 10.0k citations

Jacques Koolen's Hit Papers

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial 2013 · 333 citations
3330+10+20Years since publication50010001.5k

Peers

Jacques Koolen
Comparison fields: 5 of 127
  • Surgery 7.4k
  • Cardiology and Cardiovascular Medicine 3.6k
  • Radiology, Nuclear Medicine and Imaging 2.9k
  • Biomaterials 957
  • Pulmonary and Respiratory Medicine 1.4k
Replace Michael Haude with:
Michael Haude Germany
Evald Høj Christiansen Denmark
John A. Ormiston New Zealand
Yoshinobu Onuma Netherlands
Alexandre Abizaid Brazil
Clemens von Birgelen Netherlands
Ulrich Sigwart United Kingdom
Peter de Jaegere Netherlands
Scot Garg United Kingdom
Matteo Montorfano Italy
Jacques Koolen relative to Michael Haude Germany Michael Haude's profile →
Citations per field
00.5×1.6×
Michael Haude · 1×
Citations per year

Countries citing papers authored by Jacques Koolen

Since Specialization
Citations

This map shows the geographic impact of Jacques Koolen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Koolen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Koolen more than expected).

Fields of papers citing papers by Jacques Koolen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Koolen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Koolen. The network helps show where Jacques Koolen may publish in the future.

Co-authors

The 25 scholars most cited alongside Jacques Koolen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jacques Koolen Line = papers co-authored together Jacques Koolen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery Stenoses
Hit paper breakdown →
19961535
2
Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis
Hit paper breakdown →
20071039
3
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial
Hit paper breakdown →
2007700
4
Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis
Hit paper breakdown →
2001601
5
Predictors of Coronary Stent Thrombosis
Hit paper breakdown →
2009484
6
Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis
Hit paper breakdown →
2011414
7
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial
Hit paper breakdown →
2013333
8 2010240
9
European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club.
2007216
10 2000191
11 2014178
12 2009167
13 2012163
14 2017158
15 1998127
16 2016119
17 2009116
18 1999115
19 1999112
20 2009111

About Jacques Koolen

Jacques Koolen is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 149 papers that have together received 10.4k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (98 papers), Cardiac Imaging and Diagnostics (32 papers), Cardiac Valve Diseases and Treatments (18 papers), Cardiac, Anesthesia and Surgical Outcomes (13 papers), Acute Myocardial Infarction Research (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Hemodynamic Monitoring and Therapy (6 papers) and Peripheral Artery Disease Management (6 papers). The work is most often cited by research in Surgery (7.4k citations), Cardiology and Cardiovascular Medicine (3.6k citations), Radiology, Nuclear Medicine and Imaging (2.9k citations), Biomaterials (957 citations) and Pulmonary and Respiratory Medicine (1.4k citations). Jacques Koolen has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Bernard De Bruyne, Nico H.J. Pijls, Jozef Bartúnek, Hans Bonnier, Kathinka Peels, Pepijn H. van der Voort, William Wijns, Patrick W. Serruys, Eric Boersma and Jan C.A. Hoorntje. Their work appears in journals such as Journal of the American College of Cardiology, JACC: Cardiovascular Interventions, EuroIntervention, The American Journal of Cardiology and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact